Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 407537, 7 pages
http://dx.doi.org/10.1155/2014/407537
Research Article

Snapback Primer Mediated Clamping PCR for Detection of EGFR and KRAS Mutations in NSCLC Patients by High Resolution Melting Analysis

1State Key Laboratory of Genetic Engineering, Fudan-VARI Genetic Epidemiology Center and MOE Key Laboratory of Contemporary Anthropology, School of Life Sciences, Fudan University, 220 Handan Road, Shanghai 200433, China
2Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, 507 Zheng Min Road, Shanghai 200433, China
3Department of Thoracic and Cardiovascular Surgery, Second Military Medical University, Changhai Hospital, Shanghai 200433, China
4Department of Central Laboratory, Shanghai Pulmonary Hospital, Tongji University School of Medicine, 507 Zheng Min Road, Shanghai 200433, China

Received 18 January 2014; Accepted 21 March 2014; Published 4 May 2014

Academic Editor: Noriyoshi Sawabata

Copyright © 2014 Haiyan Sun et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. J. Gorden, P. Mesbah, and J. M. Kolesar, “EGFR inhibitors as first-line therapy in EGFR mutation-positive patients with NSCLC,” Journal of Oncology Pharmacy Practice, vol. 18, no. 2, pp. 245–249, 2012. View at Publisher · View at Google Scholar
  2. M. S. Cragg, J. Kuroda, H. Puthalakath, D. C. S. Huang, and A. Strasser, “Gefitinib-induced killing of NSCLC cell lines expressing mutant EGFR requires BIM and can be enhanced by BH3 mimetics,” PLoS Medicine, vol. 4, no. 10, article e316, 2007. View at Publisher · View at Google Scholar
  3. A. Leone, “Highly sensitive detection of EGFR T790M mutation in pre-TKI specimens of EGFR-mutated NSCLC: in cis, in trans, or a different clone?” Journal of Thoracic Oncology, vol. 8, no. 3, pp. e26–e27, 2013. View at Publisher · View at Google Scholar
  4. H. Linardou, I. J. Dahabreh, D. Bafaloukos, P. Kosmidis, and S. Murray, “Somatic EGFR mutations and efficacy of tyrosine kinase inhibitors in NSCLC,” Nature Reviews Clinical Oncology, vol. 6, no. 6, pp. 352–366, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Barron, “DNA sequencing and genotyping,” Electrophoresis, vol. 29, no. 23, p. 4617, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Maheswaran, L. V. Sequist, S. Nagrath et al., “Detection of mutations in EGFR in circulating lung-cancer cells,” The New England Journal of Medicine, vol. 359, no. 4, pp. 366–377, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Miyazawa, T. Tanaka, Y. Nagai et al., “Peptide nucleic acid-locked nucleic acid polymerase chain reaction clamp-based detection test for gefitinib-refractory T790M epidermal growth factor receptor mutation,” Cancer Science, vol. 99, no. 3, pp. 595–600, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. T. Mok, Y.-L. Wu, and L. Zhang, “A small step towards personalized medicine for non-small cell lung cancer,” Discovery Medicine, vol. 8, no. 43, pp. 227–231, 2009. View at Google Scholar · View at Scopus
  9. Q. Pan, W. Pao, and M. Ladanyi, “Rapid polymerase chain reaction-based detection of epidermal growth factor receptor gene mutations in lung adenocarcinoma,” Journal of Molecular Diagnostics, vol. 7, no. 3, pp. 396–403, 2005. View at Google Scholar · View at Scopus
  10. D. A. M. Heideman, F. B. Thunnissen, M. Doeleman et al., “A panel of high resolution melting (HRM) technology-based assays with direct sequencing possibility for effective mutation screening of EGFR and K-ras genes,” Cellular Oncology, vol. 31, no. 5, pp. 329–333, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Zhao, Q. X. Peng, B. H. Yang, and D. R. Lu, “High-resolution melting analysis for the detection of EGFR mutations in circulating DNA of lung cancer patients,” Zhonghua Yi Xue Za Zhi, vol. 91, no. 10, pp. 674–678, 2011. View at Google Scholar
  12. L. Zhou, R. J. Errigo, H. Lu, M. A. Poritz, M. T. Seipp, and C. T. Wittwer, “Snapback primer genotyping with saturating DNA dye and melting analysis,” Clinical Chemistry, vol. 54, no. 10, pp. 1648–1656, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Wang, R. Ramakrishnan, Z. Tang et al., “Quantifying EGFR alterations in the lung cancer genome with nanofluidic digital PCR arrays,” Clinical Chemistry, vol. 56, no. 4, pp. 623–632, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. C. Hu, X. Liu, Y. Chen et al., “Direct serum and tissue assay for EGFR mutation in non-small cell lung cancer by high-resolution melting analysis,” Oncology Reports, vol. 28, no. 5, pp. 1815–1821, 2012. View at Google Scholar
  15. A. Vallée, M. Marcq, A. Bizieux et al., “Plasma is a better source of tumor-derived circulating cell-free DNA than serum for the detection of EGFR alterations in lung tumor patients,” Lung Cancer, vol. 82, no. 2, pp. 373–374, 2013. View at Publisher · View at Google Scholar
  16. I. Yam, D. C. Lam, K. Chan et al., “EGFR array: uses in the detection of plasma EGFR mutations in non-small cell lung cancer patients,” Journal of Thoracic Oncology, vol. 7, no. 7, pp. 1131–1140, 2012. View at Google Scholar
  17. J. A. Bates and E. J. A. Taylor, “Scorpion ARMS primers for SNP real-time PCR detection and quantification of Pyrenophora teres,” Molecular Plant Pathology, vol. 2, no. 5, pp. 275–280, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Richter, F. Grieu, A. Carrello et al., “A multisite blinded study for the detection of BRAF mutations in formalin-fixed, paraffin-embedded malignant melanoma,” Scientific Reports, vol. 3, article 1659, 2013. View at Google Scholar
  19. M. Skronski, J. Chorostowska-Wynimko, E. Szczepulska et al., “Reliable detection of rare mutations in EGFR gene codon L858 by PNA-LNA PCR clamp in non-small cell lung cancer,” in Respiratory Regulation—The Molecular Approach, vol. 756 of Advances in Experimental Medicine and Biology, pp. 321–331, 2013. View at Publisher · View at Google Scholar